MergerLinks - Request Credit - AstraZeneca-backed Alexion completed the acquisition of the remaining stake in Caelum Biosciences from Fortress Biotech for $350m.

Submit Deal

Request Deal Involvement

AstraZeneca-backed Alexion completed the acquisition of the remaining stake in Caelum Biosciences from Fortress Biotech for $350m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

legal advisors

Alston & Bird

pr advisors

6 Degrees

Principals

bidder

ASTRAZENECA PLC

target

CAELUM BIOSCIENCES

bidder

ALEXION PHARMACEUTICALS INC

vendor

FORTRESS BIOTECH

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.

To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal: